MAX
Zeitplan Invesco Nasdaq Biotechnology ETF
Einfacher Zeitplan
Verlängerter Zeitplan
Die Hauptparameter
| 10 Sommerrentabilität | 0 |
| 3 Sommerrentabilität | -1.82 |
| 5 Sommerrentabilität | 0 |
| Asset -Typ | Equity |
| Beta | -0.86 |
| Das Datum der Basis | 2021-06-09 |
| Die Anzahl der Unternehmen | 48 |
| Durchschnittlich p/s | 4.82 |
| Durchschnittlicher P/BV | 3.66 |
| Durchschnittlicher p/e | -33.73 |
| Eigentümer | Invesco |
| Fokus | Health Care |
| Göttliche Rentabilität | 0.73 |
| ISIN -Code | US46138G5999 |
| Index | NASDAQ / Biotechnology |
| Jährliche Rentabilität | 37.34 |
| Kommission | 0.19 |
| Land | USA |
| Land ISO | US |
| Region | North America |
| Region | U.S. |
| Segment | Equity: U.S. Pharma, Biotech & Life Sciences |
| Strategie | Exchange-specific |
| Top 10 Emittenten, % | 46.43 |
| Vermögensgröße | Large-Cap |
| Webseite | System |
| Währung | usd |
| Tagsüber wechseln | 0% 28.8 $ |
| Änderung der Woche | -3.01% 29.7 $ |
| Änderung in einem Monat | -2.13% 29.43 $ |
| Änderung in 3 Monaten | +1.49% 28.38 $ |
| Änderung in sechs Monaten | +7.83% 26.71 $ |
| Änderung für das Jahr | +37.34% 20.97 $ |
| Änderung von Anfang des Jahres | -1.03% 29.1 $ |
Zahlen Sie das Abonnement
Weitere Funktionen und Daten zur Analyse von Unternehmen und Portfolio sind nach Abonnement verfügbar
Top -Unternehmen
| Name | Industrie | Aktie, % | P/BV | P/S | P/E | EV/Ebitda | Dividendenrendite | |
| #1 |
 Vertex |
Healthcare | 8.7193 | 6.28 | 9.35 | -186.72 | 205.99 | 0 |
| #2 |
 Gilead Sciences |
Healthcare | 7.7858 | 6 | 4.02 | 240.57 | 29.81 | 2.56 |
| #3 |
 Amgen |
Healthcare | 7.7143 | 23.02 | 5.43 | 25.85 | 14.15 | 3.06 |
| #4 |
 Regeneron |
Healthcare | 5.9529 | 2.75 | 5.69 | 18.33 | 15.25 | 0.23 |
| #5 |
 AstraZeneca PLC |
Healthcare | 4.1131 | 6.18 | 5.12 | 29.32 | 15.95 | 2.74 |
| #6 |
 Alnylam Pharmaceuticals, Inc. |
Healthcare | 3.9854 | 233.68 | 13.4 | -197.3 | -170.29 | 0 |
| #7 |
 Insmed Incorporated |
Healthcare | 2.7697 | 39.59 | 31.06 | -21.8 | -13.25 | 0 |
| #8 |
 Biogen |
Healthcare | 1.9882 | 1.31 | 2.26 | 13.43 | 9.25 | 0 |
| #9 |
 argenx SE |
Healthcare | 1.734 | 7.35 | 18.45 | 48.51 | 370.32 | 0 |
| #10 |
 Illumina |
Healthcare | 1.6675 | 8.95 | 4.86 | -12.66 | -31.36 | 0 |
Ähnlich ETF
Andere ETFs der Verwaltungsgesellschaft
| Name | Klasse | Kategorie | Kommission | Jährliche Rentabilität |
| Equity | 0.2 | 13.84 | ||
| Equity | 0.2 | 11.54 | ||
| Equity | 0.02 | 14.11 | ||
| Equity | 0.15 | 13.9 | ||
| Equity | 0.15 | 12.5 | ||
| Equity | 0.15 | 11.76 | ||
| Bond | 0.65 | -2.63 | ||
| Equity | 0.39 | 17.14 | ||
| Equity | 0.29 | 9.98 | ||
| Commodity | 0.59 | 17.84 | ||
| Equity | 0.2 | 13.36 | ||
| Bond | 0.1 | -0.27 | ||
| Equity | 0.4 | 17.34 | ||
| Bond | 0.1 | -0.14 | ||
| Equity | 0.58 | 33.36 | ||
| Bond | 0.1 | -0.0256 | ||
| Equity | 0.39 | 15.49 | ||
| Equity | 0.3 | 9.65 | ||
| Bond | 0.28 | 4.2 | ||
| Equity | 0.34 | 15.67 | ||
| Equity | 0.39 | 18.35 | ||
| Equity | 0.6 | 1.67 | ||
| Equity | 0.35 | 17.61 | ||
| Bond | 0.23 | -0.0199 | ||
| Bond | 0.1 | 0.33 | ||
| Commodity | 0.85 | 18.27 | ||
| Equity | 0.45 | 24.64 | ||
| Bond | 0.08 | -0.17 | ||
| Multi-Asset | 0.5 | -0.37 | ||
| Bond | 0.1 | 0.56 |
Beschreibung Invesco Nasdaq Biotechnology ETF
The fund generally will invest at least 90% of its total assets in the securities that comprise the index. Strictly in accordance with its guidelines and mandated procedures, Nasdaq compiles the underlying index, which is a modified market capitalization weighted index that is designed to measure the performance of securities listed on the Nasdaq Stock Market that are classified as either biotechnology or pharmaceutical companies. The index may include securities of large-, mid- and small-capitalization companies. The fund is non-diversified.
Basierend auf Quellen: porti.ru
